These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2967259)

  • 1. Corneal endothelial morphology in the rat. Effects of aging, diabetes, and topical aldose reductase inhibitor treatment.
    Meyer LA; Ubels JL; Edelhauser HF
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):940-8. PubMed ID: 2967259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of aldose reductase inhibitor on the corneal endothelial morphology in diabetic rats.
    Matsuda M; Awata T; Ohashi Y; Inaba M; Fukuda M; Manabe R
    Curr Eye Res; 1987 Feb; 6(2):391-7. PubMed ID: 2952464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of sorbinil, an aldose reductase inhibitor, on the corneal endothelium in galactosemic dogs.
    Datiles MB; Kador PF; Kashima K; Kinoshita JH; Sinha A
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2201-4. PubMed ID: 2122961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldose reductase in early streptozotocin-induced diabetic rat lens.
    Garadi R; Lou MF
    Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2370-5. PubMed ID: 2509397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of endothelial and smooth muscle density in the corpora cavernosa of the streptozotocin induced diabetic rat.
    Burchardt T; Burchardt M; Karden J; Buttyan R; Shabsigh A; de la Taille A; Ng PY; Anastasiadis AG; Shabsigh R
    J Urol; 2000 Nov; 164(5):1807-11. PubMed ID: 11025774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy.
    Sun W; Oates PJ; Coutcher JB; Gerhardinger C; Lorenzi M
    Diabetes; 2006 Oct; 55(10):2757-62. PubMed ID: 17003340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical localization for aldose reductase in diabetic lenses.
    Akagi Y; Kador PF; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1987 Jan; 28(1):163-7. PubMed ID: 3100473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of aldose reductase inhibitor (M79175) on ERG oscillatory potential abnormalities in streptozotocin fructose-induced diabetes in rats.
    Funada M; Okamoto I; Fujinaga Y; Yamana T
    Jpn J Ophthalmol; 1987; 31(2):305-14. PubMed ID: 3118085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of experimental diabetic corneal endotheliopathy with a new aldose reductase inhibitor].
    Terubayashi H; Akagi Y; Takahashi Y; Ikebe H; Miyamoto Y; Ibaraki N; Yokoi N; Tutumi M; Itoi M
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):151-5. PubMed ID: 3133928
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of aldose reductase inhibitor on retinal microangiopathy in streptozotocin-diabetic rats.
    Kojima K; Matsubara H; Harada T; Mizuno K; Suzuki M; Hotta N; Kakuta H; Sakamoto N
    Jpn J Ophthalmol; 1985; 29(1):99-109. PubMed ID: 3159927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal endothelial cell change after phacoemulsification relative to the severity of diabetic retinopathy.
    Lee JS; Lee JE; Choi HY; Oum BS; Cho BM
    J Cataract Refract Surg; 2005 Apr; 31(4):742-9. PubMed ID: 15899451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discoveries in research on diabetic keratopathy.
    Cisarik-Fredenburg P
    Optometry; 2001 Nov; 72(11):691-704. PubMed ID: 12363257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of aldose reductase in diabetic corneal epitheliopathy. Second report: The corneal epithelium of galactosemic rats].
    Takahashi Y; Akagi Y; Akimune M; Tamura K; Itoi M
    Nippon Ganka Gakkai Zasshi; 1986 Feb; 90(2):336-40. PubMed ID: 3085442
    [No Abstract]   [Full Text] [Related]  

  • 14. Altering the course of cataracts in diabetic rats.
    Fukushi S; Merola LO; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1980 Mar; 19(3):313-5. PubMed ID: 6766909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new approach against sugar cataract through aldose reductase inhibitors.
    Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U
    Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Water extract of Aralia elata prevents cataractogenesis in vitro and in vivo.
    Chung YS; Choi YH; Lee SJ; Choi SA; Lee JH; Kim H; Hong EK
    J Ethnopharmacol; 2005 Oct; 101(1-3):49-54. PubMed ID: 15905053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldose reductase, diabetes, and thickening of the retinal inner limiting membrane.
    Nagata M; Robison WG
    Invest Ophthalmol Vis Sci; 1987 Nov; 28(11):1867-9. PubMed ID: 3117719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of Ganoderma applanatum on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
    Jung SH; Lee YS; Shim SH; Lee S; Shin KH; Kim JS; Kim YS; Kang SS
    Phytother Res; 2005 Jun; 19(6):477-80. PubMed ID: 16114079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of specular microscopy to determine corneal endothelial cell morphology and morphometry in enucleated cat eyes.
    Franzen AA; Pigatto JA; Abib FC; Albuquerque L; Laus JL
    Vet Ophthalmol; 2010 Jul; 13(4):222-6. PubMed ID: 20618799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.
    Kador PF; Inoue J; Secchi EF; Lizak MJ; Rodriguez L; Mori K; Greentree W; Blessing K; Lackner PA; Sato S
    Exp Eye Res; 1998 Aug; 67(2):203-8. PubMed ID: 9733586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.